Javed, K.; Cheng, Q.; Carroll, A.J.; Truong, T.T.; Bröer, S.
Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)—A Potential Target to Treat Metabolic Disorders. Int. J. Mol. Sci. 2018, 19, 3597.
https://doi.org/10.3390/ijms19113597
AMA Style
Javed K, Cheng Q, Carroll AJ, Truong TT, Bröer S.
Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)—A Potential Target to Treat Metabolic Disorders. International Journal of Molecular Sciences. 2018; 19(11):3597.
https://doi.org/10.3390/ijms19113597
Chicago/Turabian Style
Javed, Kiran, Qi Cheng, Adam J. Carroll, Thy T. Truong, and Stefan Bröer.
2018. "Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)—A Potential Target to Treat Metabolic Disorders" International Journal of Molecular Sciences 19, no. 11: 3597.
https://doi.org/10.3390/ijms19113597
APA Style
Javed, K., Cheng, Q., Carroll, A. J., Truong, T. T., & Bröer, S.
(2018). Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)—A Potential Target to Treat Metabolic Disorders. International Journal of Molecular Sciences, 19(11), 3597.
https://doi.org/10.3390/ijms19113597